Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012559:Schizophrenia / Q000209:etiology; D012686:Septal Nuclei / Q000502:physiology*
D018492:Dopamine Antagonists; D001058:Apomorphine; D003913:Dextroamphetamine